Can epidemiological studies determine the productivity-related burden of COPD?

Sanja Stanojevic

Source: Eur Respir J, 50 (3) 1701515; 10.1183/13993003.01515-2017
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sanja Stanojevic. Can epidemiological studies determine the productivity-related burden of COPD?. Eur Respir J, 50 (3) 1701515; 10.1183/13993003.01515-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How to define asthma in large-scale studies?
Source: International Congress 2014 – Is asthma prevalence still increasing?
Year: 2014



Validity and interpretation of mortality, health service and survey data on COPD and asthma in England
Source: Eur Respir J 2003; 21: 279-286
Year: 2003



The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




Persistence to COPD therapies and impact on exacerbations: a French claims data study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018




External validation of exacerbation and mortality outcomes of health economic decision models for COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

An international investigation into the health status of COPD sufferers
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


Systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in patients with difficult asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 536s
Year: 2003

Epidemiological study to assess the quality of life and health care resource utilization by patients with mild COPD (EPIDEPOC)
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005

Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009

COPD and activities of the daily life: impact of the disease severity results of an epidemiological study
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


COPD heterogeneity: An epidemiological perspective from the PLATINO study
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011

The impact of a definition when assessing the cumulative incidence of exacerbation for a primary care cohort of COPD patient
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003

Measuring the impact of COPD on patients‘ lives in an international study
Source: Eur Respir J 2005; 26: Suppl. 49, 513s
Year: 2005

Does systematic assessment improve healthcare outcomes and healthcare utilisation in patients with severe asthma?
Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Year: 2011


Health care claims analysis to quantify the burden of moderate-to-severe asthma
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012

Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004

How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009

The paradox of primary care and respiratory health: evidence of benefit for people and populations with asthma and COPD
Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care
Year: 2011